---
$id: https://graph.org.ai/products/commodity/51332516
$type: Product
source: UNSPSC
code: "51332516"
title: "Bromperidol decanoate"
class: "51332500"
classTitle: "Antipsychotic butyrophenones"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromperidol decanoate

**UNSPSC Code**: 51332516
**Class**: [Antipsychotic butyrophenones](Antipsychotic butyrophenones.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent C31H41BrFNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73LG72M4LV, chemically known as decanoic acid, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester, but more generally known as bromperidol decanoate, which bears US NIH Compound Identifier 156321. European Medicines Agency schedules Bromperidol decanoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00880MIG. Most nations, for tariff and trade purposes, schedule bromperidol decanoate under HS 29333999 and SITC 51574. As of Q4 2014, BROMPERIDOL DECANOATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2CCC(CC2)F)C3CCC(CC3)BR.

